Neogen Chemicals Limited
Neogen Chemicals Limited engages in the manufacture and sale of specialty chemicals in India. It offers organo bromine compounds, such as alkyl bromide compounds, dibromoalkane compounds, bromo chloro alkanes, bromine derivatives of organoacids, bromoacid ester compounds, aromatic bromine derivatives, cyclic bromine derivatives, and speciality bromo fluro derivatives; speciality chloro compounds … Read more
Neogen Chemicals Limited (NEOGEN) - Total Liabilities
Latest total liabilities as of September 2025: ₹15.02 Billion INR
Based on the latest financial reports, Neogen Chemicals Limited (NEOGEN) has total liabilities worth ₹15.02 Billion INR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Neogen Chemicals Limited - Total Liabilities Trend (2014–2025)
This chart illustrates how Neogen Chemicals Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Neogen Chemicals Limited Competitors by Total Liabilities
The table below lists competitors of Neogen Chemicals Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Shenzhen Easttop Supply Chain Management Co Ltd
SHE:002889
|
China | CN¥2.59 Billion |
|
Hualan Biological Bacterin Inc.
SHE:301207
|
China | CN¥1.50 Billion |
|
Qingdao Hi-Tech Moulds & Plastics Technology Co. Ltd.
SHE:301022
|
China | CN¥795.71 Million |
|
Shanghai Prosolar Resources Development Co Ltd
SHG:600193
|
China | CN¥438.98 Million |
|
Road Environment Technology Co. Ltd. A
SHG:688156
|
China | CN¥811.10 Million |
|
Yibin Paper Industry Co Ltd
SHG:600793
|
China | CN¥2.93 Billion |
|
Shanghai W Ibeda High Tech Group Co Ltd
SHG:688071
|
China | CN¥1.23 Billion |
|
Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A
SHE:301290
|
China | CN¥238.50 Million |
Liability Composition Analysis (2014–2025)
This chart breaks down Neogen Chemicals Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.58 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.88 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.65 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Neogen Chemicals Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Neogen Chemicals Limited (2014–2025)
The table below shows the annual total liabilities of Neogen Chemicals Limited from 2014 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | ₹9.58 Billion | +36.63% |
| 2024-03-31 | ₹7.01 Billion | +22.73% |
| 2023-03-31 | ₹5.71 Billion | +58.68% |
| 2022-03-31 | ₹3.60 Billion | +16.53% |
| 2021-03-31 | ₹3.09 Billion | +55.56% |
| 2020-03-31 | ₹1.99 Billion | +12.69% |
| 2019-03-31 | ₹1.76 Billion | +35.58% |
| 2018-03-31 | ₹1.30 Billion | +17.80% |
| 2017-03-31 | ₹1.10 Billion | +108.47% |
| 2016-03-31 | ₹529.33 Million | +16.93% |
| 2015-03-31 | ₹452.69 Million | +4.45% |
| 2014-03-31 | ₹433.40 Million | -- |